15145163

Source:http://linkedlifedata.com/resource/pubmed/id/15145163

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0205420, umls-concept:C0684249, umls-concept:C0817096, umls-concept:C0936012, umls-concept:C1516238, umls-concept:C1522449, umls-concept:C2603343
pubmed:issue	2
pubmed:dateCreated	2004-5-17
pubmed:abstractText	To prospectively evaluate the feasibility of delivering 70 Gy once-daily thoracic radiotherapy (TRT), concurrent with chemotherapy, in the treatment of limited-stage small-cell lung cancer (L-SCLC).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA03927, http://linkedlifedata.com/resource/pubmed/grant/CA04326, http://linkedlifedata.com/resource/pubmed/grant/CA04457, http://linkedlifedata.com/resource/pubmed/grant/CA11789, http://linkedlifedata.com/resource/pubmed/grant/CA12046, http://linkedlifedata.com/resource/pubmed/grant/CA12449, http://linkedlifedata.com/resource/pubmed/grant/CA16450, http://linkedlifedata.com/resource/pubmed/grant/CA21060, http://linkedlifedata.com/resource/pubmed/grant/CA31946, http://linkedlifedata.com/resource/pubmed/grant/CA31983, http://linkedlifedata.com/resource/pubmed/grant/CA33601, http://linkedlifedata.com/resource/pubmed/grant/CA35091, http://linkedlifedata.com/resource/pubmed/grant/CA37135, http://linkedlifedata.com/resource/pubmed/grant/CA41287, http://linkedlifedata.com/resource/pubmed/grant/CA47555, http://linkedlifedata.com/resource/pubmed/grant/CA47577, http://linkedlifedata.com/resource/pubmed/grant/CA77298, http://linkedlifedata.com/resource/pubmed/grant/CA77406, http://linkedlifedata.com/resource/pubmed/grant/CA77658
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15145163-15590201
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Topotecan
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0360-3016
pubmed:author	pubmed-author:BogartJeffrey AJA, pubmed-author:Cancer and Leukemia Group B study 39808, pubmed-author:GreenMark RMR, pubmed-author:HerndonJames EJE2nd, pubmed-author:LeaMichael AMA, pubmed-author:LyssAlan PAP, pubmed-author:MillerAntonius AAA, pubmed-author:TurrisiAndrew TAT, pubmed-author:WatsonDorothyD
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	59
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	460-8
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15145163-Adult, pubmed-meshheading:15145163-Aged, pubmed-meshheading:15145163-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15145163-Carboplatin, pubmed-meshheading:15145163-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:15145163-Feasibility Studies, pubmed-meshheading:15145163-Female, pubmed-meshheading:15145163-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:15145163-Humans, pubmed-meshheading:15145163-Lung Neoplasms, pubmed-meshheading:15145163-Male, pubmed-meshheading:15145163-Middle Aged, pubmed-meshheading:15145163-Paclitaxel, pubmed-meshheading:15145163-Prospective Studies, pubmed-meshheading:15145163-Radiotherapy Dosage, pubmed-meshheading:15145163-Remission Induction, pubmed-meshheading:15145163-Survival Analysis, pubmed-meshheading:15145163-Topotecan
pubmed:year	2004
pubmed:articleTitle	70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
pubmed:affiliation	Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA. BogartJ@Upstate.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Multicenter Study, Clinical Trial, Phase II